On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. Since then, the virus has claimed millions of lives and has transformed nearly every aspect of individual and collective reality.
This spotlight outlines the main impacts of COVID 19 pandemic on drug availability and use in Europe and discusses how services established to tackle drug-related problems have responded to emerging challenges. It also considers some implications for the future. It was developed as a component of the Health and social responses to drug problems: a European guide 2021.